Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00063 |
| Species: | Homo sapiens |
| Position : | chr8:128821774-128822358 |
| Year: | 2018 |
| Title: | Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast cancer |
| PMID: | 29731168 |
| MONDO: | MONDO:0007254 |
| Tissue: | breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | MDA-MB-231 |
| CVCL ID: | CVCL_0062 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; Functional perturbation assay; Chromatin interaction assay; Promoter-enhancer competition assay; Endogenous enhancer perturbation; Disease-variant functional analysis; In vivo functional validation |
| High Throughput Method: | H3K27ac HiChIP |
| Low Throughput Method: | CRISPRi; UMI-4C; Luciferase Reporter Assay; qRT-PCR; ChIP-qPCR; CRISPR-Cas9 endogenous deletion/editing; In vivo phenotyping |
| Target gene : | MYC |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|